Cervical cancer web-based clinical decision support tool
Home Back
- Preferred regimens
For patients not previously treated with chemotherapy
1) Pembrolizumab+Paclitaxel+Cisplatin(Carboplatin)±Bevacizumab, if all the drugs are available and PD-L1(+)
2) Paclitaxel+Cisplatin(Carboplatin)+Bevacizumab
- Recurrence after first-line platinum-based chemotherapy
- Cemiplimab, if the drug is available and PD-L1(+)
- Pembrolizumab, if the drug is available and PD-L1(+)
- Tisotumab vedotin-tftv
